Daiichi Sankyo Company, Limited (4568) - Financial and Strategic SWOT Analysis Review

Date: September 7, 2016
Pages: 65
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: DB4C12A2F14EN
Leaflet:

Download PDF Leaflet

Daiichi Sankyo Company, Limited (4568) - Financial and Strategic SWOT Analysis Review
Daiichi Sankyo Company, Limited (4568) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Daiichi Sankyo Company, Limited (Daiichi Sankyo) is a holding company that carries out the research, development, manufacture, and marketing of pharmaceutical products. The company offers a wide range of prescription drugs, over-the-counter (OTC) drugs, and quasi-drugs. The company classified its business operations into two segments, namely, Daiichi Sankyo Group segment and Ranbaxy Group segment. The company markets its products directly through its Japanese and global group companies. Daiichi Sankyo sells its products in more than 50 countries through a large network of medical representatives. The company operates across North America, South America, Europe and Asia Pacific. Daiichi Sankyo is headquartered in Tokyo, Japan.

Daiichi Sankyo Company, Limited Key Recent Developments

Sep 06, 2016: Daiichi Sankyo Announces New Global Head of Development
Aug 23, 2016: Daiichi Sankyo Selects Veeva Vault to Streamline Submissions, eTMF, and Quality Management
Jun 30, 2016: FTSE Russell Selects Daiichi Sankyo for FTSE4Good Global Index
Jun 23, 2016: Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology 9th Annual Clinical Pharmacology Research Award
Jun 16, 2016: Daiichi Sankyo Launches New Generic Drugs Through Its Daiichi Sankyo Espha Subsidiary

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company. - The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably. - Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance. - Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research. - Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Daiichi Sankyo Company, Limited - Key Facts
Daiichi Sankyo Company, Limited - Key Employees
Daiichi Sankyo Company, Limited - Key Employee Biographies
Daiichi Sankyo Company, Limited - Major Products and Services
Daiichi Sankyo Company, Limited - Pharmaceutical Pipeline Products Data
Daiichi Sankyo Company, Limited, Pipeline Products by Therapy Area
Daiichi Sankyo Company, Limited, Pipeline Products by Development Phase
Daiichi Sankyo Company, Limited - History
Daiichi Sankyo Company, Limited - Company Statement
Daiichi Sankyo Company, Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Daiichi Sankyo Company, Limited - Business Description
Daiichi Sankyo Company, Limited - Corporate Strategy
Daiichi Sankyo Company, Limited - SWOT Analysis
SWOT Analysis - Overview
Daiichi Sankyo Company, Limited - Strengths
Strength - Sturdy Research and Development Activities
Strength - Strong Product Pipeline
Daiichi Sankyo Company, Limited - Weaknesses
Weakness - Product Discontinuations
Daiichi Sankyo Company, Limited - Opportunities
Opportunity - Market Potential Cancer
Opportunity - Strategic Agreements
Opportunity - New Product Launches
Daiichi Sankyo Company, Limited - Threats
Threat - Regulations
Threat - Uncertain R&D Outcomes
Threat - Presence of Counterfeit Drugs
Daiichi Sankyo Company, Limited - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Financial Performance
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Daiichi Sankyo Company, Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Daiichi Sankyo Company, Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Daiichi Sankyo Company, Limited, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 06, 2016: Daiichi Sankyo Announces New Global Head of Development
Aug 23, 2016: Daiichi Sankyo Selects Veeva Vault to Streamline Submissions, eTMF, and Quality Management
Jun 30, 2016: FTSE Russell Selects Daiichi Sankyo for FTSE4Good Global Index
Jun 23, 2016: Daiichi Sankyo’s Japan Research Foundation for Clinical Pharmacology 9th Annual Clinical Pharmacology Research Award
Jun 16, 2016: Daiichi Sankyo Launches New Generic Drugs Through Its Daiichi Sankyo Espha Subsidiary
May 12, 2016: Daiichi Sankyo Announces Changes to Representative Director and Members of the Board
May 06, 2016: The outcome of arbitration proceeding with certain former shareholders of Ranbaxy
Apr 05, 2016: Open innovation research on new stem cells by Asahikawa Medical University, Daiichi Sankyo, and Mitsubishi UFJ Capital
Mar 31, 2016: Daiichi Sankyo Announces 5-year Business Plan (FY 2016 - FY 2020)
Mar 31, 2016: Daiichi Sankyo Announces Closure of Daiichi Sankyo Chemical Pharma Hiratsuka Plant

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Daiichi Sankyo Company, Limited, Key Facts
Daiichi Sankyo Company, Limited, Key Employees
Daiichi Sankyo Company, Limited, Key Employee Biographies
Daiichi Sankyo Company, Limited, Major Products and Services
Daiichi Sankyo Company, Limited, Number of Pipeline Products by Therapy Area
Daiichi Sankyo Company, Limited, Number of Pipeline Products by Development Stage
Daiichi Sankyo Company, Limited, Pipeline Products By Therapy Area and Development Phase
Daiichi Sankyo Company, Limited, History
Daiichi Sankyo Company, Limited, Subsidiaries
Daiichi Sankyo Company, Limited, Joint Venture
Daiichi Sankyo Company, Limited, Key Competitors
Daiichi Sankyo Company, Limited, Ratios based on current share price
Daiichi Sankyo Company, Limited, Annual Ratios
Daiichi Sankyo Company, Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Daiichi Sankyo Company, Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Daiichi Sankyo Company, Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Daiichi Sankyo Company, Limited, Pipeline Products by Therapy Area
Daiichi Sankyo Company, Limited, Pipeline Products by Development Phase
Daiichi Sankyo Company, Limited, Ratio Charts
Daiichi Sankyo Company, Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Daiichi Sankyo Company, Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
Skip to top


Ask Your Question

Daiichi Sankyo Company, Limited (4568) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: